TRK-3 Performance of Pachymetry

Normal Clinical Trial

Official title:

TRK-3 Agreement and Precision of Pachymetry Function

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06250868
• Other study ID #: THQ-THINC-2023-03
• Status: Completed
• Start date: February 20, 2024
• Est. completion date: February 26, 2024

Study information

• Verified date: February 2024
• Source: Topcon Corporation
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluate the performance of a new tonometer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: February 26, 2024
• Est. primary completion date: February 26, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 22 Years and older

Eligibility

Inclusion Criteria:

1. Provide voluntary written consent for participation in the study.

2. Age at least 22 years old at the time of informed consent.

Exclusion Criteria:

1. Ocular condition that may affect the ability to perform corneal measurement (e.g., corneal perforation, bullous keratopathy, nystagmus)

2. Have or is suspected to have an ocular infection in either eye.

3. Otherwise considered unsuitable for the study by the investigator

4. Unable to tolerate ophthalmic testing.

Related Conditions & MeSH terms

• Normal

Intervention

Device:
• Kerato-Refracto Tonometer
measures pressure inside the eye and thickness of the cornea.

Locations

Country	Name	City	State
United States	Topcon Healthcare Innovation Center	La Jolla	California

Sponsors (1)

Lead Sponsor	Collaborator
Topcon Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cornea thickness	Thickness of the cornea	1 day